Volume 8, Issue 3
The April 2013 SNMMI-ACNM Health Policy and Regulatory Affairs (HPRA) Newsletter is now available.
Featured in this issue, among other topics:
*SNMMI prepares important comments for CMS
*Update:Mallinckrodt customer letter on the supply of Mo-99
*SNMMI applauds FDA approval of Tc99m Tilmanocept (Lymphoseek)
*CARE Act reintroduced
If you would like to be notified of future SNMMI-ACNM HPRA Newsletters via email, please send your name and preferred email address to hpra@snmmi.org.